← FDA DRUG APPROVALS

FDA ANDA · ANDA076698

METOLAZONE

Sponsor: MYLAN

APPLICATION
ANDA076698
TYPE
ANDA
ORIGINAL APPROVAL
2003-12-23
LATEST ACTION
2004-10-19
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

METOLAZONEPrescription
METOLAZONE 5MG · TABLET · ORAL
METOLAZONEPrescription
METOLAZONE 10MG · TABLET · ORAL
METOLAZONEPrescription
METOLAZONE 2.5MG · TABLET · ORAL

Approval history

2004-10-19Supplement · Supplement 3AP
2004-10-19Supplement · Supplement 1AP
2004-10-19Labeling · Supplement 4AP
2004-10-19Labeling · Supplement 2AP
2003-12-23OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →